The Clindamycin Injection, cataloged under National Stock Number 6505-01-185-3309, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Fresenius Kabi, Llc. Government technical data includes 6 specifications, cited from the U.S. Government catalog. The record lists 2 manufacturer part numbers for this item, enabling identification through both NSN and commercial part number lookups. 4 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. 6 items share a part number with this NSN in the catalog (possible match — not a government interchangeability claim). Current acquisition status: Active. Unit of issue: PG.
| Parameter | Value |
|---|---|
| NSN | 6505-01-185-3309 |
| Primary Part Number | NDC63323-0282-02 |
| Item Name | Clindamycin Injection |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Fresenius Kabi, Llc |
| Status | ACTIVE |
| Administration | INTRAMUSCULAR OR INTRAVENOUS |
| Primary Container Content Quantity | 2.000 MILLILITERS |
| Medical Designation and Grade | UNITED STATES PHARMACOPEIA |
| Primary Container Type | VIAL |
| Active Medicament Medicinal Strength | 150.000 MILLIGRAMS CLINDAMYCIN EQUIVALENT PER MILLILITER |
| Total Primary Container Quantity | 25 |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Hazardous per DLA record (HMIC Y) |
| Criticality Code | X |
| Unit of Issue | PG |
| Part Number | Manufacturer |
|---|---|
| NDC63323-0282-02 PRIMARY | Fresenius Kabi, Llc (USA) |
| NDC47781-0459-68 PRIMARY | Alvogen, Inc. (USA) |
| Reference | Meaning |
|---|---|
| NDC00009-0870-26 | 3/2 Design control — primary reference U.S. Government activity |
| 28202 | 5/9 Secondary reference Hig Dfw Airport Dba Hawthorn Suites Dfw Airport |
| NDC00409-4050-01 | 5/9 Secondary reference Hospira, Inc. |
| CLEOCIN | 5/1 Secondary reference U.S. Government activity |
NSN 6505-01-185-3309 is a Clindamycin Injection, manufactured by Fresenius Kabi, Llc, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-185-3309 has 2 manufacturer part numbers on file: NDC63323-0282-02 (Fresenius Kabi, Llc), NDC47781-0459-68 (Alvogen, Inc.).
6 possible matches (shared part number, not a government interchangeability claim): 6145-01-342-7430, 4250-01-398-6788, 6210-01-407-0588. Verify interchangeability with system specifications before substitution.
Key specifications for NDC63323-0282-02: Administration: INTRAMUSCULAR OR INTRAVENOUS; Primary Container Content Quantity: 2.000 MILLILITERS; Medical Designation and Grade: UNITED STATES PHARMACOPEIA; Primary Container Type: VIAL. 6 specifications are documented in the U.S. Government catalog.
Hazardous per DLA record (HMIC Y). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.